Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome

Comment

Marc A Pfeffer et al. N Engl J Med. 2016.

. 2016 Mar 17;374(11):1095-6.

doi: 10.1056/NEJMc1600140.

No abstract available

Comment on

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Clinical Trial.
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Tsutsumi Y, Tsujimoto Y, Ikenoue T. Tsutsumi Y, et al. N Engl J Med. 2016 Mar 17;374(11):1094-5. doi: 10.1056/NEJMc1600140. N Engl J Med. 2016. PMID: 26981946 No abstract available.
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Derosa G, Maffioli P. Derosa G, et al. N Engl J Med. 2016 Mar 17;374(11):1095. doi: 10.1056/NEJMc1600140. N Engl J Med. 2016. PMID: 26981947 No abstract available.